The inhibitory effect of VitD3 on proliferation of keratinocyte cell line HACAT is mediated by down-regulation of CXCR2 expression

Clinical and Experimental Dermatology

Volumn 28, Issue 4, 2003, Pages 416-419

  Tang, L ^a   Yu, Y ^b   Chen, J ^a   Li, Q ^a   Yan, M ^a   Guo, Z ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; COLECALCIFEROL; INTERLEUKIN 8; ANTIINFLAMMATORY AGENT;

ARTICLE; BIOASSAY; CELL LINE; CELL PROLIFERATION; CELL STRAIN HACAT; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; CULTURE TECHNIQUE; DOWN REGULATION; METABOLISM; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; CELL CULTURE TECHNIQUES; CHOLECALCIFEROL; DOWN-REGULATION; HUMANS; KERATINOCYTES; PSORIASIS; RECEPTORS, INTERLEUKIN-8B;

EID: 0141789737     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2003.01269.x     Document Type: Article

References (22)

1. Duvic M, Asano AT, Hager C, Mays S. The pathogenesis of psoriasis and the mechanism of action of tazarotene. J Am Acad Dermatol 1998; 39: S129-33.
2. Raychaudhuri SP, Jiang WY, Farber EM et al. Upregulation of RANTES in psoriatic keratinocytes: a possible pathogenic mechanism for psoriasis. Acta Derm Venereol 1999; 70: 9-11.
3. Rottman JB, Smith TL, Ganley KG et al. Potential role of the chemokine receptors CXCR3, CCR4, and the integrin alphaEbeta7 in the pathogenesis of psoriasis vulgaris. Laboratory Invest 2001; 81: 335-47.
4. Horuk R. Chemokine receptors. Cytokine Growth Factor Rev 2001; 12: 313-35.
5. Nelson PJ, Krensky AM. Chemokines, chemokine receptors, and allograft rejection. Immunity 2001; 14: 377-86.
6. Tuschil A, Lam C, Haslberger A et al. Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. J Invest Dermatol 1992; 99: 294-8.
7. Gillitzer R, Ritter U, Spandau U et al. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 1996; 107: 635-43.
8. Premack BA, Schall TJ. Chemokine receptors: Gateway to inflammation and infection. Nature Med 1996; 2: 1174-8.
9. Kulke R, Bornscheuer E, Schluter C et al. The CXC receptor 2 is overexpressed in psoriatic epidermis. J Invest Dermatol 1998; 110: 90-4.
10. Kowalzick L. Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis. Br J Dermatol 2001; 144 (Suppl. 58): 21-5.
11. Matsumoto K, Hashimoto K, Kiyoki M et al. Effect of 1,24R-dihydroxyvitD3 on the growth of human keratinocytes. J Dermatol 1990; 17: 97-103.
12. Boisseau-Garsaud AM, Donatien P, Margerin C et al. EGF receptor expression and growth of psoriatic and normal human keratinocytes are modulated by 1.25 (OH) 2-vitamin D3 ex vivo. Arch Dermatol Res 1996; 288: 453-7.
13. Piemonti L, Monti P, Sironi M et al. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164: 4443-51.
14. Sokoloski JA, Sartorelli AC. Induction of the differentiation of HL-60 promyelocytic leukemia cells by nonsteroidal anti-inflammatory agents in combination with low levels of vitamin D3. Leuk Res 1998; 22: 153-61.
15. Fukuoka M, Ogino Y, Sato H et al. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Br J Dermatol 1998; 138: 63-70.
16. Matsumoto K, Hashimoto K, Hashiro M et al. Modulation of growth and differentiation in normal human keratinocytes by transforming growth factor-β. J Cell Physiol 1990; 145: 95-101.
17. Boorsma DM, Flier J, Sampat S et al. Chemokine IP-10 expression in cultured human keratinocytes. Arch Dermatol Res 1998; 290: 335-41.
18. Godaly G, Hang L, Frendeus B et al. Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol 2000; 165: 5287-94.
19. Biasi D, Carletto A, Caramaschi P et al. Neutrophil functions and IL-8 in psoriatic arthritis and in cutaneous psoriasis. Inflammation 1998; 22: 533-43.
20. Gillitzer R, Berger R, Mielke V et al. Upper keratinocyte of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol, 1991; 97: 73-9.
21. Anttila HIS, Reitamo S, Erkko P et al. IL-8 immunoreactivity in the skin of healthy subjects and patients with psoriasis. J Invest Dermatol 1992; 98: 96-101.
22. Duan H, Koga T, Kohda F et al. Interleukin-8-positive neutrophils in psoriasis. J Dermatol Sci 2001; 26: 119-24.